ECSP055741A - Nuevo método para la síntesis industrial de ranelato de estroncio y los hidratos del mismo - Google Patents
Nuevo método para la síntesis industrial de ranelato de estroncio y los hidratos del mismoInfo
- Publication number
- ECSP055741A ECSP055741A EC2005005741A ECSP055741A ECSP055741A EC SP055741 A ECSP055741 A EC SP055741A EC 2005005741 A EC2005005741 A EC 2005005741A EC SP055741 A ECSP055741 A EC SP055741A EC SP055741 A ECSP055741 A EC SP055741A
- Authority
- EC
- Ecuador
- Prior art keywords
- ranelato
- estroncio
- hydrats
- same
- new method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Inorganic Insulating Materials (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
La invención se relaciona con un método para la síntesis industrial de ranelato de estroncio de fórmula (I) y los hidratos del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0211763A FR2844795B1 (fr) | 2002-09-24 | 2002-09-24 | Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP055741A true ECSP055741A (es) | 2005-07-06 |
Family
ID=29415189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2005005741A ECSP055741A (es) | 2002-09-24 | 2005-04-22 | Nuevo método para la síntesis industrial de ranelato de estroncio y los hidratos del mismo |
Country Status (38)
Country | Link |
---|---|
US (1) | US7214805B2 (es) |
EP (1) | EP1403266B1 (es) |
JP (1) | JP4136867B2 (es) |
KR (1) | KR100551501B1 (es) |
CN (1) | CN1212321C (es) |
AP (1) | AP1910A (es) |
AR (1) | AR041355A1 (es) |
AU (2) | AU2003282179A1 (es) |
BR (1) | BR0304213A (es) |
CA (1) | CA2442878C (es) |
CR (1) | CR7764A (es) |
CY (1) | CY1115162T1 (es) |
DK (1) | DK1403266T3 (es) |
EA (1) | EA007489B1 (es) |
EC (1) | ECSP055741A (es) |
ES (1) | ES2478620T3 (es) |
FR (1) | FR2844795B1 (es) |
GE (1) | GEP20074215B (es) |
HK (1) | HK1065791A1 (es) |
HR (1) | HRP20050359B1 (es) |
IL (1) | IL167316A (es) |
IS (1) | IS7807A (es) |
MA (1) | MA26102A1 (es) |
ME (1) | ME00455B (es) |
MX (1) | MXPA03008643A (es) |
MY (1) | MY134921A (es) |
NO (1) | NO328638B1 (es) |
NZ (1) | NZ528402A (es) |
OA (1) | OA12934A (es) |
PL (1) | PL214400B1 (es) |
PT (1) | PT1403266E (es) |
RS (2) | RS20050240A (es) |
SG (1) | SG110071A1 (es) |
SI (1) | SI1403266T1 (es) |
TN (1) | TNSN05087A1 (es) |
UA (1) | UA79156C2 (es) |
WO (1) | WO2004029036A1 (es) |
ZA (1) | ZA200307409B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2266584T1 (sl) * | 2003-05-07 | 2012-12-31 | Osteologix A/S, Symbion | Sestavek s stroncijem in vitaminom D za profilakso in/ali zdravljenje patologij hrustanca in/ali kosti |
PT1534305E (pt) * | 2003-05-07 | 2007-02-28 | Osteologix As | Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis |
KR101165614B1 (ko) | 2004-02-26 | 2012-07-18 | 오스테올로지스 에이에스 | 괴사성 골 질환의 예방 또는 치료에 사용하기 위한스트론튬 함유 화합물 |
EP1744770A2 (en) * | 2004-05-06 | 2007-01-24 | Osteologix A/S | High yield and rapid syntheses methods for producing metallo-organic salts |
BRPI0512357A (pt) | 2004-06-25 | 2008-03-04 | Strontin Aps | composições compreendendo estrÈncio e vitamina d e usos destas |
FR2875807B1 (fr) * | 2004-09-30 | 2006-11-17 | Servier Lab | Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
CN100538672C (zh) * | 2005-04-18 | 2009-09-09 | 索尼株式会社 | 控制设备和方法 |
CN100391955C (zh) * | 2005-04-30 | 2008-06-04 | 河北医科大学 | 一种雷尼酸锶中间体的合成方法 |
CA2619720A1 (en) * | 2005-08-19 | 2007-02-22 | Glenmark Pharmaceuticals Limited | Process for the preparation of strontium ranelate |
US20070292529A1 (en) * | 2006-06-19 | 2007-12-20 | Tabbiner Philip S | Strontium compositions and methods of treating osteoporotic conditions |
US20070292535A1 (en) * | 2006-06-19 | 2007-12-20 | Tabbiner Philip S | Strontium compositions and methods of treating arthritic and or osteoporitic conditions |
FR2921367B1 (fr) * | 2007-09-26 | 2009-10-30 | Servier Lab | Nouveau procede de synthese du ranelate de strontium et de ses hydrates |
US20120123131A1 (en) * | 2008-08-22 | 2012-05-17 | Koilpillai Joseph Prabahar | Process for the preparation of strontium ranelate |
HU228820B1 (en) | 2010-01-14 | 2013-05-28 | Richter Gedeon Nyrt | Process for the preparation of distrontium ranelate |
WO2011110597A1 (de) | 2010-03-11 | 2011-09-15 | Azad Pharmaceutical Ingredients Ag | Verfahren zur herstellung von strontiumranelat |
WO2011124992A1 (en) * | 2010-03-24 | 2011-10-13 | Actavis Group Ptc Ehf | Substantially pure strontium ranelate |
US9301945B2 (en) | 2011-07-21 | 2016-04-05 | Emory University | Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation |
CN102321068B (zh) * | 2011-08-01 | 2013-01-23 | 山东铂源药业有限公司 | 一种雷奈酸锶的制备方法 |
WO2013175270A1 (en) * | 2012-05-25 | 2013-11-28 | Fleming Laboratories Limited | Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate |
EP2756841B1 (en) | 2013-01-21 | 2015-05-13 | Galenicum Health S.L. | Pharmaceutical compositions comprising an acid salt |
CN103319454B (zh) * | 2013-06-14 | 2014-06-18 | 广东众生药业股份有限公司 | 一种高纯度雷尼酸四乙酯及其中间体的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2651497B1 (fr) * | 1989-09-01 | 1991-10-25 | Adir | Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
FR2749759B1 (fr) * | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
FR2844797B1 (fr) * | 2002-09-24 | 2004-10-22 | Servier Lab | Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
FR2844796A1 (fr) * | 2002-09-24 | 2004-03-26 | Servier Lab | Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
-
2002
- 2002-09-24 FR FR0211763A patent/FR2844795B1/fr not_active Expired - Fee Related
-
2003
- 2003-09-17 MY MYPI20033542A patent/MY134921A/en unknown
- 2003-09-22 AP AP2005003256A patent/AP1910A/xx active
- 2003-09-22 AU AU2003282179A patent/AU2003282179A1/en not_active Abandoned
- 2003-09-22 WO PCT/FR2003/002777 patent/WO2004029036A1/fr not_active Application Discontinuation
- 2003-09-22 OA OA1200500083A patent/OA12934A/en unknown
- 2003-09-22 ES ES03292319.5T patent/ES2478620T3/es not_active Expired - Lifetime
- 2003-09-22 SI SI200332352T patent/SI1403266T1/sl unknown
- 2003-09-22 EP EP03292319.5A patent/EP1403266B1/fr not_active Expired - Lifetime
- 2003-09-22 ME MEP-2008-689A patent/ME00455B/me unknown
- 2003-09-22 RS YUP-2005/0240A patent/RS20050240A/sr unknown
- 2003-09-22 AU AU2003248281A patent/AU2003248281B2/en not_active Ceased
- 2003-09-22 GE GEAP20048761A patent/GEP20074215B/en unknown
- 2003-09-22 RS RSP20050240 patent/RS53509B1/en unknown
- 2003-09-22 JP JP2003330440A patent/JP4136867B2/ja not_active Expired - Fee Related
- 2003-09-22 UA UAA200503858A patent/UA79156C2/uk unknown
- 2003-09-22 PT PT3292319T patent/PT1403266E/pt unknown
- 2003-09-22 DK DK03292319.5T patent/DK1403266T3/da active
- 2003-09-23 BR BR0304213-8A patent/BR0304213A/pt not_active Application Discontinuation
- 2003-09-23 EA EA200300925A patent/EA007489B1/ru not_active IP Right Cessation
- 2003-09-23 NZ NZ528402A patent/NZ528402A/en not_active IP Right Cessation
- 2003-09-23 KR KR1020030065783A patent/KR100551501B1/ko not_active IP Right Cessation
- 2003-09-23 CA CA002442878A patent/CA2442878C/fr not_active Expired - Fee Related
- 2003-09-23 PL PL362365A patent/PL214400B1/pl unknown
- 2003-09-23 MX MXPA03008643A patent/MXPA03008643A/es active IP Right Grant
- 2003-09-23 AR ARP030103453A patent/AR041355A1/es not_active Application Discontinuation
- 2003-09-23 ZA ZA200307409A patent/ZA200307409B/xx unknown
- 2003-09-23 NO NO20034235A patent/NO328638B1/no not_active IP Right Cessation
- 2003-09-24 MA MA27321A patent/MA26102A1/fr unknown
- 2003-09-24 SG SG200305555A patent/SG110071A1/en unknown
- 2003-09-24 US US10/669,301 patent/US7214805B2/en not_active Expired - Fee Related
- 2003-09-24 CN CNB031348130A patent/CN1212321C/zh not_active Expired - Fee Related
-
2004
- 2004-11-01 HK HK04108552A patent/HK1065791A1/xx not_active IP Right Cessation
-
2005
- 2005-03-08 IL IL167316A patent/IL167316A/en not_active IP Right Cessation
- 2005-03-18 CR CR7764A patent/CR7764A/es unknown
- 2005-03-23 TN TNP2005000087A patent/TNSN05087A1/fr unknown
- 2005-04-19 IS IS7807A patent/IS7807A/is unknown
- 2005-04-21 HR HRP20050359AA patent/HRP20050359B1/hr not_active IP Right Cessation
- 2005-04-22 EC EC2005005741A patent/ECSP055741A/es unknown
-
2014
- 2014-06-05 CY CY20141100397T patent/CY1115162T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055741A (es) | Nuevo método para la síntesis industrial de ranelato de estroncio y los hidratos del mismo | |
YU5503A (sh) | Nesteroidni supresori zapaljenja | |
EA200801884A1 (ru) | Новый способ синтеза ранелата стронция и его гидратов | |
CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
CR7680A (es) | Un nuevo proceso para la sintesis de agomelatina | |
SE0000540D0 (sv) | New compounds | |
CY1113362T1 (el) | Διαρυλ-αιθερες, ως ανταγωνιστης οπιοειδους υποδοχεως | |
EA200500201A1 (ru) | Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина | |
ECSP055743A (es) | Nuevo proceso para la sintesis industrial de tetraésteres del acido 5-[bis(carboximetil)amino]-3-carboximetil-4-ciano-2- tiofeno carboxílico y aplicación para la síntesis de sales bivalentes de acido ranelico y sus hidratos | |
IL185275A0 (en) | N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same | |
ECSP055742A (es) | Nuevo método para la síntesis industrial de diéster de metilo del ácido 5-amino-3-carboximetil-4-ciano-2-tiofencarboxílico y aplicación para la síntesis de sales bivalentes de ácido ranélico y sus hidratos | |
EA200500202A1 (ru) | Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина | |
ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
TNSN05277A1 (en) | Novel bioisosteres of actinonin | |
EA200601086A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
ATE349427T1 (de) | Tryptaseinhibitoren | |
GB0314299D0 (en) | Chemical compounds | |
SE0301794D0 (sv) | New use III | |
CU20080181A7 (es) | Nuevo procedimiento de síntesis del ranelato de estroncio y de sus hidratos | |
ECSP003583A (es) | Forma cristalina iii de la n-[4-(5- dimetilaminonaftalen-1-sulfonilamino) fenil]-3-hidroxi-2,2-dimetilpropionamida (caso lea 33884-ec) |